sellWeak cluster of 210b5-1 plan
SAHA SAURABH sold $1.0M of CNTA
Chief Executive Officer at Centessa Pharmaceuticals plc. 60,182 shares at an average of $17.00, traded Nov 20, 2024, filed Nov 22, 2024.
Warning score
23Value
$1.0M
60,182 shares
Holdings after
575,661
-10% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-24-000171, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -55,000 | $16.89 | $929k | 575,661 | Nov 22, 2024 |
| Nov 21, 2024 | MOption exercise Ordinary Shares | +3,511 | $5.84 | $21k | 579,172 | Nov 22, 2024 |
| Nov 21, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -3,511 | $18.24 | $64k | 575,661 | Nov 22, 2024 |
| Nov 22, 2024 | MOption exercise Ordinary Shares | +1,671 | $5.84 | $9,759 | 577,332 | Nov 22, 2024 |
| Nov 22, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -1,671 | $18.24 | $30k | 575,661 | Nov 22, 2024 |
| Nov 21, 2024 | MOption exercise Share Option (right to buy)derivative | -3,511 | $0.00 | $0 | 3,958,951 | Nov 22, 2024 |
| Nov 22, 2024 | MOption exercise Share Option (right to buy)derivative | -1,671 | $0.00 | $0 | 3,957,280 | Nov 22, 2024 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 6Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | Weinhoff Gregory M Chief Business Officer | $170k | 10,000 | |
| 44Moderate | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | SAHA SAURABH Chief Executive Officer | $959k | 55,000 | |
| 14Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | Anderson Karen M. Chief People Officer | $284k | 16,500 | |
| 18Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | Bush Tia L Chief Technology & Quality Ofc | $478k | 27,424 | |
| 30Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | HUSSAIN IQBAL J General Counsel | $1.3M | 77,705 | |
| 35Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | SAHA SAURABH Chief Executive Officer | $1.6M | 87,496 | |
| 0Weak | sell 210b5-1 | CNTA Centessa Pharmaceuticals plc | Weinhoff Gregory M Chief Business Officer | $177k | 10,000 | |
| 0Weak | sell 210b5-1 | CNTA Centessa Pharmaceuticals plc | SAHA SAURABH Chief Executive Officer | $5,451 | 299 | |
| 17Weak | sell 210b5-1 | CNTA Centessa Pharmaceuticals plc | SAHA SAURABH Chief Executive Officer | $585k | 32,023 | |
| 15Weak | sell 210b5-1 | CNTA Centessa Pharmaceuticals plc | Weinhoff Gregory M Chief Business Officer | $181k | 11,742 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.